GUT HEALTH TIPS
Screening for Colorectal Cancer: what are the options other than colonoscopy?
Colorectal cancer (CRC) is the third most common cancer worldwide and a leading cause of cancer-related deaths. Early detection through effective screening significantly improves outcomes. For individuals at average risk, understanding the available screening strategies is essential for prevention and timely diagnosis.
🎯 Who Is Considered “Average Risk”?
Patients at average risk typically:
Are aged 45 or older
Have no personal or family history of colorectal cancer or adenomatous polyps
Do not have inflammatory bowel disease (e.g., Crohn’s or ulcerative colitis)
Have no genetic syndromes like Lynch syndrome or familial adenomatous polyposis
🧪 Top Screening Strategies for Average-Risk Patients
1. Fecal Immunochemical Test (FIT)
Frequency: Annually
Pros: Non-invasive, no prep, home-based
Cons: Requires yearly testing, may miss some polyps
SEO Tip: Keywords: FIT test for colon cancer, non-invasive CRC screening
2. Colonoscopy
Frequency: Every 10 years
Pros: Gold standard, allows polyp removal
Cons: Requires bowel prep, sedation, and time off work
SEO Tip: Keywords: colonoscopy screening, best test for colon cancer
3. Flexible Sigmoidoscopy
Frequency: Every 5 years (or every 10 years with annual FIT)
Pros: Less invasive than colonoscopy
Cons: Only examines lower colon
SEO Tip: Keywords: sigmoidoscopy vs colonoscopy, lower colon cancer screening
4. Stool DNA Test (e.g., Cologuard)
Frequency: Every 3 years
Pros: Detects DNA changes and blood
Cons: Higher false-positive rate, follow-up colonoscopy needed if positive
SEO Tip: Keywords: Cologuard test, DNA stool test for colon cancer
📅 When Should Screening Begin?
Age 45 is the recommended starting point for average-risk individuals, per updated guidelines from the American Cancer Society.
Earlier screening may be advised based on symptoms or family history.
🧠 Choosing the Right Strategy
Factors to consider:
Personal preference (comfort, convenience)
Access to healthcare services
Insurance coverage
Risk tolerance for false positives or missed lesions
Shared decision-making between patients and providers ensures the most suitable approach.
Latest Articles
- Difficulty Passing motion? Don’t worry, there is a hope to retrain your bowel
- Severe Reflux Disease? Try Vonoprazan
- 益生元 (Prebiotics)、益生菌 (Probiotics)、后生元 (Postbiotics) 的区别,以及它们对肠道健康的重要性
- Acorn Gastroenterology胃肠科:新加坡领先的胃肠护理
- Ozempic 与 Wegovy:疗效、风险与胃痛解析
Popular Categories
Gut Condition (16) Gut Health Tips (54) Gut Symptom (10) Services (9) Uncategorised (1) 病状 (6) 症状 (1) 肠道健康文章 (4)





